Starling Oncology (STLN) Cash from Operations Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | -44.54% |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -37.50% |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 4.59% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 51.15% |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | -19.25% |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 10.42% |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -38.81% |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 157.75% |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 52.99% |
| 10 | Starling Oncology | 609.95 Mn | 568.85 Mn | 27.17 Mn | 217.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.04% |
| Mar 31, 2026 | 55.59% |
| Dec 31, 2025 | -19.17% |
| Sep 30, 2025 | -1,642.12% |
| Jun 30, 2025 | 34.85% |
| Mar 31, 2025 | 68.60% |
| Dec 31, 2024 | 202.75% |
| Sep 30, 2024 | 109.86% |
| Jun 30, 2024 | -80.83% |
| Mar 31, 2024 | -2.79% |
| Dec 31, 2023 | 72.19% |
| Sep 30, 2023 | 59.26% |
| Jun 30, 2023 | 16.56% |
| Mar 31, 2023 | 9.00% |
| Dec 31, 2022 | 40.02% |
| Sep 30, 2022 | -661.44% |
| Jun 30, 2022 | -45.57% |
| Mar 31, 2022 | -3,759.70% |
| Dec 31, 2021 | -2,412.82% |
| Sep 30, 2021 | -3,759.17% |